These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 669855)

  • 21. The specific cytotoxic effects of daunomycin conjugated to antitumor antibodies.
    Levy R; Hurwitz E; Maron R; Arnon R; Sela M
    Cancer Res; 1975 May; 35(5):1182-6. PubMed ID: 164280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies as carriers of anticancer agents.
    Rubens RD
    Lancet; 1974 Mar; 1(7856):498-9. PubMed ID: 4131895
    [No Abstract]   [Full Text] [Related]  

  • 23. Protection of mice against syngeneic lymphomata: I. Use of antibodies.
    Davies DA; Manstone AJ; Buckham S
    Br J Cancer; 1974 Oct; 30(4):297-304. PubMed ID: 4217193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of human alpha-foetoprotein-producing hepatocellular carcinoma growth in nude mice by an anti alpha-foetoprotein antibody-daunorubicin conjugate with a poly-L-glutamic acid derivative as intermediate drug carrier.
    Tsukada Y; Ohkawa K; Hibi N
    Br J Cancer; 1985 Jul; 52(1):111-6. PubMed ID: 2410001
    [No Abstract]   [Full Text] [Related]  

  • 25. Reduced toxicity of daunorubicin by conjugation to dextran.
    Levi-Schaffer F; Bernstein A; Meshorer A; Arnon R
    Cancer Treat Rep; 1982 Jan; 66(1):107-14. PubMed ID: 6171348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experimental models of immunochemotherapeutic synergism: study of the influence of the treatment schedule].
    Circolo A; Bianchi R; Nardelli B; Romani L; Andrielli M
    Boll Soc Ital Biol Sper; 1979 Oct; 55(19):1974-80. PubMed ID: 554636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Daunomycin--immunoglobulin conjugates, uptake and activity in vitro.
    Hurwitz E; Maron R; Arnon R; Wilchek M; Sela M
    Eur J Cancer (1965); 1978 Nov; 14(11):1213-20. PubMed ID: 738327
    [No Abstract]   [Full Text] [Related]  

  • 28. Site-directed tumor chemotherapy.
    Arnon R
    Compr Ther; 1978 Apr; 4(4):68-73. PubMed ID: 348397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy and rate of kill of tumor cells in a mouse plasmacytoma.
    Hiramoto RN; Ghanta VK
    Cancer Res; 1974 Jul; 34(7):1738-42. PubMed ID: 4833918
    [No Abstract]   [Full Text] [Related]  

  • 30. Synergistic action of cyclophosphamide and 1,3-bis(2-chloroethyl)-1-nitrosourea on a transplanted murine lymphoma.
    Valeriote FA; Bruce WR; Meeker BE
    J Natl Cancer Inst; 1968 May; 40(5):935-44. PubMed ID: 5648137
    [No Abstract]   [Full Text] [Related]  

  • 31. Tumor-bound immunoglobulins: an in vivo phenomenon of masked specificity.
    Dorval G; Wilz IP; Klein E; Wigzell H
    J Natl Cancer Inst; 1976 Mar; 56(3):523-7. PubMed ID: 56447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Murine neuroblastoma cured in vivo by an antibody-dependent cellular cytotoxicity reaction.
    Byfield JE; Zerubavel R; Fonkalsrud EW
    Nature; 1976 Dec 23-30; 264(5588):783-5. PubMed ID: 1012319
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of drug-antibody conjugates in the treatment of human myelosarcomas transplanted in nude mice.
    Latif ZA; Lozzio BB; Wust CJ; Krauss S; Aggio MC; Lozzio CB
    Cancer; 1980 Mar; 45(6):1326-33. PubMed ID: 6928397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of daunorubicin (NSC-83142) with adriamycin (NSC-123127) in the treatment of late-stage childhood solid tumors.
    Evans AE; Baehner RL; Chard RL; Leikin SL; Pang EM; Pierce M
    Cancer Chemother Rep; 1974; 58(5 Pt 1):671-6. PubMed ID: 4371948
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of anti-idiotypic antibody-drug conjugates to treat experimental murine B-cell tumors.
    Hurwitz E; Haimovich J
    Methods Enzymol; 1989; 178():369-75. PubMed ID: 2601626
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of a conjugate of daunomycin and purified polyclonal or monoclonal antibodies to rat alpha-fetoprotein on the growth of alpha-fetoprotein-producing tumor cells.
    Tsukada Y; Hurwitz E; Kashi R; Sela M; Hibi N; Hara A; Hirai H
    Ann N Y Acad Sci; 1983; 417():262-9. PubMed ID: 6200034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of antigen, drug, and tumor cell targets in the preclinical evaluation of doxorubicin, daunorubicin, methotrexate, and mitomycin-C monoclonal antibody immunoconjugates.
    Dillman RO; Johnson DE; Ogden J; Beidler D
    Mol Biother; 1989; 1(5):250-5. PubMed ID: 2515870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor effect of 2-thio-4-hydrazinouracil on transplantable tumors.
    Golovinsky EV; Emanuilov EA; Spassovska NC; Spassov AV
    Neoplasma; 1975; 22(3):255-8. PubMed ID: 1161120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Murine natural anti-tumor antibodies. I. Rapid in vivo binding of natural antibody by tumor cells in syngeneic mice.
    Wolosin LB; Greenberg AH
    Int J Cancer; 1979 Apr; 23(4):519-29. PubMed ID: 437926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.